Interaction with Regulatory Authorities. All interaction with Regulatory Authorities (both written and oral) that directly affects the Product or Production shall be conducted in accordance with the provisions of this Section 6. At RevitaLid’s request, Nephron will authorize Regulatory Authorities to review on RevitaLid’s behalf applications related to the Production.
Appears in 2 contracts
Sources: Exclusive Supply Agreement (Osmotica Pharmaceuticals PLC), Exclusive Supply Agreement (Osmotica Pharmaceuticals LTD)